PROCEPT BioRobotics（納斯達克股票代碼：PRCT）報告第四季度每股虧損$(0.35)，低於分析師普遍預期的$(0.33)，低於6.06%。這一數據較去年同期每股虧損$(0.54)增長了35.19%。公司報告季度銷售額爲$68.2百萬，高於分析師普遍預期的$66.78百萬，上漲了2.13%。這一數據較去年同期的銷售額$43.581百萬增長了56.49%。

以上內容來自Benzinga Earnings專欄，原文如下：

PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.33) by 6.06 percent. This is a 35.19 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $68.200 million which beat the analyst consensus estimate of $66.780 million by 2.13 percent. This is a 56.49 percent increase over sales of $43.581 million the same period last year.